https://www.switzerlandhealthmonitor.com/article/906126854-txone-networks-achieves-cybersecurity-certification-with-sgs Switzerland Health Monitor en PressRelease 2026-04-16T15:54:19+00:00 TXOne Networks achieves cybersecurity certification with SGS https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834447-2886-txone-1728x1012.jpeg https://www.switzerlandhealthmonitor.com/article/906078423-maintmaster-verzeichnet-starke-nachfrage-nach-ki-f-r-industrielle-instandhaltung-und-produktion Switzerland Health Monitor en PressRelease 2026-04-16T10:18:06+00:00 Maintmaster verzeichnet starke Nachfrage nach KI für industrielle Instandhaltung und Produktion https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23951193-maintmaster-manufacturing-intel-1200x628.png https://www.switzerlandhealthmonitor.com/article/906101366-helsinn-appoints-giacomo-braglia-to-the-board-of-directors Switzerland Health Monitor en PressRelease 2026-04-16T12:00:00+00:00 Helsinn appoints Giacomo Braglia to the Board of Directors https://ml-eu.globenewswire.com/media/5159c168-3b3f-444e-bbee-456218d74062/small/helsinn-logo-h-helsinn-blue-and-grey-1-png.png https://www.switzerlandhealthmonitor.com/article/906040574-bioversys-announces-first-patient-first-visit-in-habp-vabp-pivotal-phase-3-riv-target-trial-of-bv100 Switzerland Health Monitor en PressRelease 2026-04-16T05:00:00+00:00 BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100 https://ml.globenewswire.com/media/37dee549-5eb0-418f-a16c-11d8422babfb/small/logo-bioversys-color-rgb-neu-for-prs-jpg.jpg https://www.switzerlandhealthmonitor.com/article/905865492-doctor-bernhard-scheja-on-ultrasound-as-a-non-invasive-diagnostic-method Switzerland Health Monitor en PressRelease 2026-04-15T10:28:14+00:00 Doctor Bernhard Scheja on Ultrasound as a Non-Invasive Diagnostic Method https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24833238-bernhard-scheja-1328x768.png https://www.switzerlandhealthmonitor.com/article/905476169-sarla-technologies-joins-the-aveva-partner-ecosystem-as-a-system-integrator-with-focus-on-aveva-pi-system Switzerland Health Monitor en PressRelease 2026-04-15T07:00:00+00:00 Sarla Technologies Joins the AVEVA Partner Ecosystem as a System Integrator with Focus on AVEVA PI System https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831268-aveva-pi-partnership-announceme-1920x1080.png https://www.switzerlandhealthmonitor.com/article/905913948-what-if-you-could-reboot-sick-cells Switzerland Health Monitor en PressRelease 2026-04-15T15:00:00+00:00 What if you could reboot sick cells? https://ml-eu.globenewswire.com/media/e93daf2c-fee9-4db8-8c09-bab3a01da23b/medium/targeted-mitochondrial-delivery.jpg https://www.switzerlandhealthmonitor.com/article/905897427-annual-general-meeting-of-kuros-biosciences-approves-all-resolutions Switzerland Health Monitor en PressRelease 2026-04-15T13:00:00+00:00 Annual General Meeting of Kuros Biosciences approves all resolutions https://ml-eu.globenewswire.com/media/ad3777c9-af1f-4b09-a899-3b3d6b8e962d/small/kuros-logo-jpg.jpg